Research Options:
Select below
IPO Calendar
Week of Expected Pricing
Pending
Company Name
HOVERINK BIOTECHNOLOGIES, INC
Proposed Ticker
HVBH
CUSIP
N/A
Business Description
An innovative preclinical biopharmaceutical company committed to the discovery development, manufacturing and commercializing LADAVRUŽ and biosimilars
Lead Underwriter
N/A
Co-Managers
N/A
Initial Shares
2,000,000
Revised Initial Shares
N/A
Initial Price
$20.00-$20.00
Revised Price
N/A
Final Price
N/A
Final Ticker
N/A
© 2024 ICE Data Services. All rights reserved.
